Frank L. Greenway MDMedical Director and Professor, Pennington Biomedical Research Center of the Louisiana State University System, Baton Rouge, Louisiana
Frank Greenway, MD, is a professor and director for the Outpatient Research Unit at Pennington Biomedical Research Center in Baton Rouge. He graduated from Stanford University, obtained his medical degree from the UCLA, did his internal medicine and endocrinology training at Harbor-UCLA and has boards in internal medicine and endocrinology. Dr. Greenway practiced internal medicine, endocrinology and taught at Harbor-UCLA for 20 years before coming to the Pennington as a Professor. His interest is in developing new treatments for obesity including drugs, dietary herbal supplements, medical foods and devices. His laboratory focuses on identifying food plants that have the potential to aid in weight loss. Dr. Greenway has served as the principal investigator on numerous clinical trials and is a member of a number of professional societies including the American College of Physicians (fellow), The Obesity Society (fellow). In addition to publishing more than 250 articles, Dr. Greenway also holds several patents.
DisclosuresDr. Greenway reports the following:
- Scientific Advisory Board: Pfizer,
- Consultant: Basic Research, General Nutrition Corporation
- Stock or Stock options: NovMeta Pharma, Ketogenic Health Systems, Slim Health Nutrition, UR Labs, Plensat, Energesis, Rejuvenate Bio
- Joint Patent: Melior Discoveries